Table 3.

Characterization of Long-Term Surviving Animals (B10) Reconstituted With Mobilized PB From B10.BR Donors Treated With FL Alone, G-CSF Alone, or FL + G-CSF

Donor Treatment n Donor Chimerism*B-Cells (%)αβTCR+ T Cells (%)γδTCR+ T Cells (%)NK Cells (%)Granulocytes (%)Macrophages (%)
FL  >99%  57.5 ± 14.6  22.1 ± 8.0  0.6 ± 0.1 2.3 ± 0.7  40.4 ± 5.4  35.2 ± 7.5  
G-CSF  >99%  71.3 ± 0.8  15.0 ± 7.4  0.5 ± 0.1 2.0 ± 0.8  41.3 ± 10.5  61.9 ± 0.8 
FL + G-CSF  6  >99%  48.7 ± 5.4 24.5 ± 7.8  0.7 ± 0.2  2.3 ± 0.4 24.4 ± 4.8  33.4 ± 8.4 
Donor Treatment n Donor Chimerism*B-Cells (%)αβTCR+ T Cells (%)γδTCR+ T Cells (%)NK Cells (%)Granulocytes (%)Macrophages (%)
FL  >99%  57.5 ± 14.6  22.1 ± 8.0  0.6 ± 0.1 2.3 ± 0.7  40.4 ± 5.4  35.2 ± 7.5  
G-CSF  >99%  71.3 ± 0.8  15.0 ± 7.4  0.5 ± 0.1 2.0 ± 0.8  41.3 ± 10.5  61.9 ± 0.8 
FL + G-CSF  6  >99%  48.7 ± 5.4 24.5 ± 7.8  0.7 ± 0.2  2.3 ± 0.4 24.4 ± 4.8  33.4 ± 8.4 

PB was obtained from representative recipients 6 months after reconstitution. PBMC were stained with lineage- and donor-specific MoAbs for three-color flow cytometric analysis.

*

Level of donor chimerism was calculated on gated lymphocytes with positive staining for donor (H-2Kk) but negative staining for recipient MHC class I (H-2Kb).

The mean percentage (±SD) of PBMC with positive staining for lineage- and donor-specific MoAbs on gated lymphocytes.

The mean percentage (±SD) of PMBC with positive staining for lineage- and donor-specific MoAbs on gated granulocytes.